Novo Nordisk says all its manufacturing plants will run on renewable electricity by 2020

Novo Nordisk ($NVO), the Danish maker of insulin, said all of its global manufacturing facilities will run on electricity generated from renewable sources by 2020. Currently, the company's facilities in Denmark, Brazil and Japan use electricity from renewable sources, and last month its facilities in Tianjin, China, signed an agreement to buy electricity from a windmill farm based in Mongolia. Novo Nordisk says it will reach similar agreements in the coming years for its plants in the U.S., France, Russia, Algeria and Iran. Story

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.